Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? - PubMed (original) (raw)
Review
Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?
Craig M Powell et al. Biol Psychiatry. 2006.
Abstract
Animal models are extremely useful tools in defining pathogenesis and treatment of human disease. Creating adequate animal models of complex neuropsychiatric disorders such as schizophrenia represents a particularly difficult challenge. In the case of schizophrenia, little is certain regarding the etiology or pathophysiology of the human disease. In addition, many symptoms of the disorder are difficult to measure directly in rodents. These challenges have not daunted neuroscientists who are capitalizing on even subtle overlaps between this uniquely human disorder and rodent behavior. In this perspective, we detail the features of ideal animal models of schizophrenia, the potential utility of such models, and the rodent behaviors used to model certain aspects of schizophrenia. The development of such models will provide critical tools to understand the pathogenesis of schizophrenia and novel insights into therapeutic approaches to this complex disorder.
Similar articles
- Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S, Harvey BH. Korff S, et al. Psychiatr Clin North Am. 2006 Jun;29(2):371-90. doi: 10.1016/j.psc.2006.02.007. Psychiatr Clin North Am. 2006. PMID: 16650714 Review. - Behavioral animal models of antipsychotic drug actions.
Peleg-Raibstein D, Feldon J, Meyer U. Peleg-Raibstein D, et al. Handb Exp Pharmacol. 2012;(212):361-406. doi: 10.1007/978-3-642-25761-2_14. Handb Exp Pharmacol. 2012. PMID: 23129339 Review. - Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders.
Sarnyai Z, Alsaif M, Bahn S, Ernst A, Guest PC, Hradetzky E, Kluge W, Stelzhammer V, Wesseling H. Sarnyai Z, et al. Int Rev Neurobiol. 2011;101:203-38. doi: 10.1016/B978-0-12-387718-5.00008-0. Int Rev Neurobiol. 2011. PMID: 22050853 Review. - Animal models of schizophrenia.
Young JW, Zhou X, Geyer MA. Young JW, et al. Curr Top Behav Neurosci. 2010;4:391-433. doi: 10.1007/7854_2010_62. Curr Top Behav Neurosci. 2010. PMID: 21312408 Review. - Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.
Takao K, Yamasaki N, Miyakawa T. Takao K, et al. Neurosci Res. 2007 Jun;58(2):124-32. doi: 10.1016/j.neures.2007.02.009. Epub 2007 Feb 20. Neurosci Res. 2007. PMID: 17524507 Review.
Cited by
- Advanced paternal age as a risk factor for neurodevelopmental disorders: a translational study.
Krug A, Wöhr M, Seffer D, Rippberger H, Sungur AÖ, Dietsche B, Stein F, Sivalingam S, Forstner AJ, Witt SH, Dukal H, Streit F, Maaser A, Heilmann-Heimbach S, Andlauer TFM, Herms S, Hoffmann P, Rietschel M, Nöthen MM, Lackinger M, Schratt G, Koch M, Schwarting RKW, Kircher T. Krug A, et al. Mol Autism. 2020 Jun 23;11(1):54. doi: 10.1186/s13229-020-00345-2. Mol Autism. 2020. PMID: 32576230 Free PMC article. - GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes.
Yu Z, Fang Q, Xiao X, Wang YZ, Cai YQ, Cao H, Hu G, Chen Z, Fei J, Gong N, Xu TL. Yu Z, et al. PLoS One. 2013 Jul 29;8(7):e69883. doi: 10.1371/journal.pone.0069883. Print 2013. PLoS One. 2013. PMID: 23922840 Free PMC article. - Psychosocial Stress Induces Schizophrenia-Like Behavior in Mice With Reduced MMP-9 Activity.
Vafadari B, Mitra S, Stefaniuk M, Kaczmarek L. Vafadari B, et al. Front Behav Neurosci. 2019 Aug 29;13:195. doi: 10.3389/fnbeh.2019.00195. eCollection 2019. Front Behav Neurosci. 2019. PMID: 31555105 Free PMC article. - Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.
O'Tuathaigh CM, Kirby BP, Moran PM, Waddington JL. O'Tuathaigh CM, et al. Schizophr Bull. 2010 Mar;36(2):271-88. doi: 10.1093/schbul/sbp125. Epub 2009 Nov 24. Schizophr Bull. 2010. PMID: 19934211 Free PMC article. - Muskelin regulates actin-dependent synaptic changes and intrinsic brain activity relevant to behavioral and cognitive processes.
Muhia M, YuanXiang P, Sedlacik J, Schwarz JR, Heisler FF, Gromova KV, Thies E, Breiden P, Pechmann Y, Kreutz MR, Kneussel M. Muhia M, et al. Commun Biol. 2022 Jun 15;5(1):589. doi: 10.1038/s42003-022-03446-1. Commun Biol. 2022. PMID: 35705737 Free PMC article.
References
- Alvarez P, Wendelken L, Eichenbaum H. Hippocampal formation lesions impair performance in an odor-odor association task independently of spatial context. Neurobiol Learn Mem. 2002;78:470–476. - PubMed
- Ambrosini A, De Pasqua V, Afra J, Sandor PS, Schoenen J. Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: Another indication of abnormal sensory processing? Neurosci Lett. 2001;306:132–134. - PubMed
- American Psychiatric Association. 4th ed. Washington DC: American Psychiatric Association; 2000. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR.
- Andreasen NC, Flaum M, Swayze VW, 2nd, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry. 1990;47:615–621. - PubMed
Publication types
MeSH terms
Grants and funding
- K08 MH065975-04/MH/NIMH NIH HHS/United States
- K08 MH065975/MH/NIMH NIH HHS/United States
- MH065975-01A1/MH/NIMH NIH HHS/United States
- K08 MH065975-05/MH/NIMH NIH HHS/United States
- K08 MH065975-03/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical